Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06319807 · ClinicalTrials.gov registry record · NA

GrowWell - Responsive Bottle Feeding

A NA study of Bottle Feeding, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
69
Enrollment target
1
Study location

NCT06319807: Completed NA study of Bottle Feeding, sponsored by Wake Forest University Health Sciences.

NCT06319807 is a NA study of Bottle Feeding that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06319807, a NA study of Bottle Feeding, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this research is use digital health to augment the clinical encounter with Women, Infants, and Children (WIC) clinicians and prevent rapid infant weight gain among children living in low-income households. Intervening on weight gain during infancy offers an opportunity to influence lifelong obesity risk. Using personalized motivational messages and targeted skills-training resources, the intervention will support parents and caregivers in adopting responsive feeding strategies. Knowledge gained from this project will be used to develop a future, larger grant submission focused on developing healthy feeding and eating habits among mother-infant dyads.

Primary Outcome

Engagement will be assessed by reporting the average text message completion rate over the 12-week intervention period.

Conditions Studied

Interventions

  • BEHAVIORAL Digital Health Intervention
  • BEHAVIORAL Safety Control

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2024-10-28
Est. Completion 2025-08-18
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT06319807 record still lists

NCT06319807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Bottle Feeding appearing as the primary indexed condition, and to 2 interventions - of which Digital Health Intervention is the first listed.

NCT06319807 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06319807 about?

NCT06319807 is a clinical study titled "GrowWell - Responsive Bottle Feeding". The overall goal of this research is use digital health to augment the clinical encounter with Women, Infants, and Children (WIC) clinicians and prevent rapid infant weight gain among children living in low-income households. Intervening on weight gain during infancy offers an opportunity to influen...

What is the current status of trial NCT06319807?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2024-10-28. Estimated completion is 2025-08-18.

What conditions does trial NCT06319807 study?

This clinical trial studies the following conditions: Bottle Feeding.

What interventions are being tested in trial NCT06319807?

The interventions under investigation include: Digital Health Intervention (BEHAVIORAL), Safety Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT06319807?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06319807 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bottle Feeding

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06319807's enrollment target sits among peer trials

69 1133rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06319807, the US trial registry maintained by the National Library of Medicine. NCT06319807 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.